Mycenax Biotech Inc.

EN

Please enter the company code as 4726 http://emops.twse.com.tw/server-java/t58query Go to Link

Monocloneantibody Development Platform

Mycenax’ Monocloneantibody Development Platform speeds up the development of the manufacturing process and analytical methods for your monoclonal antibody.

Technology Platform

  • Cell Culture Process Development
    • Limited media and feed finetuning by mini-bioreactor
    • Cell culture adaptation by 5L scale bioreactor
  • Purification Process Development
    • Consists of three column steps, one virus inactivation step, and one nanofiltration step
    • Limited development to remove the impurity to a safety level
  • Analytical Method Development
    • Test of in-house established analytical methods for suitability
    • If platform methods are not suitable, customized method development possible
  • Process development time can be shortened to 6 months